Owners, management and financials
CVR: 38546880
Not available
Novo Holdings A/S (20-24,99%), Danmarks Eksport- og Investeringsfond (10-14,99%)
3 more
CVR · view owners
Andrew Thomas Hotchkiss
Board: Eva-Lotta Coulter (chair) and 5 members
CVR · view management
Active
Founded 4 April 2017
CVR · view overview
11 employees
CVR · 2026
Owner registered: INKEF Holding Coöperatief U.A.
CVR · 29/06/2026
View the full event history
Draupnir Bio ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andrew Thomas Hotchkiss. The board consists of Eva-Lotta Coulter (chair), Emmanuelle Coutanceau, Ivan Burkov and Robert Andrew Donald Scott. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Coöperatieve Gilde Healthcare IV U.A.. The company has 11 employees (2026). Equity in the 2025 report amounted to DKK 15,256,000.
Selskabets formål er at forske i, udvikle, producere og sælge bioteknologiske produkter og medicinalprodukter samt anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | - | 39.1 mio. | 15.3 mio. | 9 | |
| 202401/01/2024 – 31/12/2024 | - | - | 35 mio. | 27.6 mio. | 8 | |
| 202301/01/2023 – 31/12/2023 | - | -41.2 mio. | 36.2 mio. | 29.4 mio. | 10 | |
| 202201/01/2022 – 31/12/2022 | - | -39.9 mio. | 28.4 mio. | 18.6 mio. | 13 | |
| 202101/01/2021 – 31/12/2021 | - | -67 mio. | 67.9 mio. | 53.5 mio. | - | |
| 202001/01/2020 – 31/12/2020 | - | -60.6 mio. | 60.8 mio. | 54.2 mio. | - | |
| 201901/01/2019 – 31/12/2019 | -15.9 mio. | -15.2 mio. | 53.4 mio. | 52 mio. | 2 | |
| 201801/01/2018 – 31/12/2018 | -1.8 mio. | -2.1 mio. | 4.6 mio. | -1.8 mio. | 1 |
Compared to 1.038 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorThe CVR number of Draupnir Bio ApS is 38546880.
The owners of Draupnir Bio ApS include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Coöperatieve Gilde Healthcare IV U.A..
The management of Draupnir Bio ApS consists of Andrew Thomas Hotchkiss.
The board of Draupnir Bio ApS consists of Eva-Lotta Coulter, Emmanuelle Coutanceau and Ivan Burkov, with Eva-Lotta Coulter as chair.
Draupnir Bio ApS had 11 employees in 2026 according to the Danish CVR register.
Draupnir Bio ApS was founded on 4 April 2017.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 51500560, new email: [email protected], new website: www.draupnir.bio (July 14, 2026).
As of June 29, 2026, is registered as an owner of Draupnir Bio ApS with an ownership share of 20%.
Draupnir Bio ApS has published its annual report for 2025.
Draupnir Bio ApS has published its annual report for 2024.
As of July 10, 2024, Novo Holdings A/S is registered as an owner of Draupnir Bio ApS with an ownership share of 20%.
As of July 10, 2024, Danmarks Eksport- og Investeringsfond is registered as an owner of Draupnir Bio ApS with an ownership share of 10%.
As of July 10, 2024, is registered as an owner of Draupnir Bio ApS with an ownership share of 20%.
Draupnir Bio ApS has published its annual report for 2023. The net result was DKK -41,166,000.
As of March 26, 2024, is registered as an owner of Draupnir Bio ApS with an ownership share of 10%.
Draupnir Bio ApS has published its annual report for 2022. The net result was DKK -39,890,000.
Draupnir Bio ApS has published its annual report for 2021. The net result was DKK -67,044,000.
As of February 24, 2022, Ivan Burkov has joined the board of directors of Draupnir Bio ApS.
As of February 24, 2022, Roel Bulthuis has left the board of directors of Draupnir Bio ApS.
Draupnir Bio ApS has published its annual report for 2020. The net result was DKK -60,620,000.
As of June 9, 2021, Emmanuelle Coutanceau has joined the board of directors of Draupnir Bio ApS.
As of June 9, 2021, Eva-Lotta Coulter has joined the board of directors of Draupnir Bio ApS.
As of June 8, 2021, Emmanuelle Coutanceau has left the board of directors of Draupnir Bio ApS.
As of June 1, 2021, Andrew Thomas Hotchkiss is registered as director of Draupnir Bio ApS.
As of June 1, 2021, Simon Glerup Pedersen has stepped down as director of Draupnir Bio ApS.
As of September 3, 2020, Robert Andrew Donald Scott has joined the board of directors of Draupnir Bio ApS.
Draupnir Bio ApS has published its annual report for 2019. Gross profit came to DKK -15,909,546, and the net result was DKK -15,194,060.
As of May 25, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Draupnir Bio ApS.
As of May 25, 2020, A/S PSE 17 NR. 1056 has stepped down as auditor of Draupnir Bio ApS.
As of April 30, 2020, Roel Bulthuis has joined the board of directors of Draupnir Bio ApS.
As of April 30, 2020, Fiona MacLaughlin has left the board of directors of Draupnir Bio ApS.
As of October 23, 2019, Simon Glerup Pedersen has joined the board of directors of Draupnir Bio ApS.
As of October 23, 2019, Fiona MacLaughlin has joined the board of directors of Draupnir Bio ApS.
As of October 23, 2019, Stefan Emanuel Luzi has joined the board of directors of Draupnir Bio ApS.
As of October 23, 2019, Peter Hans Andreas Seeberger has left the board of directors of Draupnir Bio ApS.
Draupnir Bio ApS has published its annual report for 2018. Gross profit came to DKK -1,779,479, and the net result was DKK -2,117,554.
As of October 26, 2018, Emmanuelle Coutanceau has joined the board of directors of Draupnir Bio ApS.
As of October 26, 2018, Peter Hans Andreas Seeberger has joined the board of directors of Draupnir Bio ApS.
As of October 26, 2018, Camilla Gustafsen has left the board of directors of Draupnir Bio ApS.
As of October 26, 2018, Simon Glerup Pedersen has left the board of directors of Draupnir Bio ApS.
As of October 26, 2018, Peder Søndergaard Madsen has left the board of directors of Draupnir Bio ApS.
Draupnir Bio ApS has published its interim report for the period April 4, 2017 to December 31, 2017.
As of April 4, 2017, A/S PSE 17 NR. 1056 has been appointed auditor of Draupnir Bio ApS.
As of April 4, 2017, Camilla Gustafsen has joined the board of directors of Draupnir Bio ApS.
As of April 4, 2017, Simon Glerup Pedersen has joined the board of directors of Draupnir Bio ApS.
As of April 4, 2017, Peder Søndergaard Madsen has joined the board of directors of Draupnir Bio ApS.
As of April 4, 2017, Simon Glerup Pedersen is registered as director of Draupnir Bio ApS.
Draupnir Bio ApS was founded on April 4, 2017.
Companies in the same industry and area
CVR 40766383
CVR 42597333
CVR 46613139
CVR 44504332
CVR 43917897
